Antibody Activity Against Lipopolysaccharides, Lipid a and Proteins from Enterobacteriacae in Patients with Chronic Inflammatory Liver Diseases

References

• Cremer N, Watson D W. Influence of stress and distribution of endotoxin RES determined by fluorescein antibody technique. Proc Soc Exp Biol Med 1957; 95: 510–513
   PubMed Web of Science ®Google Scholar
• Noyes H E, McIntuf C R, Blahuta G J. Studies on distribution of E.coli endotoxin in mice. Proc Soc Exp Biol Med 1959; 100: 65–68
   PubMedGoogle Scholar
• Di Luzio N R, Crafton C G. Influence of altered reticuloendothelial function of vascular clearance and tissue distribution of S. Enteritidis endotoxin. Proc Soc Exp Biol Med 1969; 132: 686–690
   PubMedGoogle Scholar
• Musson R A, Morrison D C, Ulevitich R J. Distribution of endotoxin (lipopolysaccharides) in the tissue of lipoposaccharide-responsive and unresponsive mice. Infect Imrnunol 1978; 21: 448–457
   PubMedGoogle Scholar
• Mathison J C, Ulevitch R J. The clearance, tissue distribution and cellular localization of intravenously injected lipopolysaccharides in rabbits. J Immunol 1979; 123: 2133–2134
   PubMed Web of Science ®Google Scholar
• Mathison J C, Ulevitch R J, Fletcher J R, Cochrane C G. The distribution of lipopolysaccharide in normo-complementemicand 3–depleted rabbits and rhesus monkeys. Am J Pathol 1980; 101: 245–264
   PubMedGoogle Scholar
• Ramadori G, Hopf U, Galanos C, Freudenberg M, Meyer zum Büschenfelde K H. In virro and in vivo reactivity of lipopolysaccharides and lipid A with parenchymal and nonparenchymal liver cells in mice. The reticuloendothelial system (RES) and pathogenesis of liver disease, H. Liehr, M. Grün. Elsevier/North-Holland Biomedical Press, Amsterdam 1980; 285–295
   Google Scholar
• Maitrd S K, Rachmilewitz D, Eberle D, Karlowitz N. The hepatocellular uptake and biliary exretion of endotoxins in the rat. Hepatology; 1981; 1: 401407
   Google Scholar
• Pruning- van Dalen D P, Brouver A, Knook D L. Clearance capacity of rat liver Kupffer, endothelial and parenchymal cells. Gastroenterology,; 1981; 81: 1036–1044
   PubMedGoogle Scholar
• Ruiter D J, van der Meulen J, Brouwer A, Hummel MJR, Mauw B J, van der Ploeg J CM, Wisse E. The uptake by liver cells of endotoxin following its intravenous injection. Lab Invest 1981; 45: 38–45
   PubMed Web of Science ®Google Scholar
• Hopf U, Ramadori G, Möller B, Galanos C. Hepatocellular Clearance Function of Bacterial Lipopolysaccharides and Free Lipid A in Mice with Endotoxic Shock. Amer J Emergency Med 1984; 2: 13–19
   PubMedGoogle Scholar
• Pryz H, Holst-Christensen J, Korner S, Liehr H. Portal venous and systemic endotoxemia in patients without liver disease and endotoxemia in patients with cirrhosis. Scand J Gastroenterol 1976; 11: 857–863
   PubMedGoogle Scholar
• Cohen I R, Norins L C. Antibodies of the IgG. IgM, and IgA classes in newborn and adult sera reactive with Gram negative bacteria. J Clin Invest 1968; 47: 1053
   PubMedGoogle Scholar
• Protell R I, Soloway R D, Martin W J, Schoenfield L J, Summerskill W HJ. Anti-salmonella agglutinis in chronic active liver disease. Lancet 1971; 11: 330–332
   Google Scholar
• Triger D R, Alp M H, Wright R. Bacterial and dietary antibodies in liver disease. Lancet 1972; 1: 60–63
   PubMed Web of Science ®Google Scholar
• Bjoerneboe M, Prytz H, Orskov F. Antibodies to intestinal microbes in serum of patients with cirrhosis of the liver. Lancet 1972; 1: 58–60
   PubMedGoogle Scholar
• Prytz H, Bjoerneboe M, Orskov F, Hilden M. Antibodies to Escherichia coli in alcoholic and non-alcoholic patients with cirrhosis of the liver or fatty liver. Scand J Gastroenterology 1973; 8: 433–438
   PubMed Web of Science ®Google Scholar
• Simjee A E, Hamilton-Miller J MT, Thomas H C, Brumfitt W, Sherlock S. Antibodies to Escherichia coli in chronic liver disease. Cut 1975; 16: 871–875
   Google Scholar
• Prytz H, Bjoerneboe M, Christoffersen P, Poulsen H, Orskov F. Correlation between hepatic morphology and immunoglobulins and antibodies to Escherichia coli in cirrhosis. Gut 1977; 18: 28–32
   PubMedGoogle Scholar
• Hedle R J, Shermann D JC. Serum antibodies to Escherichia coli in subjects with ulcerative colitis. Clinical Experimental Immunology 1979; 38: 22–30
   PubMedGoogle Scholar
• Triger D R, Boyer T D, Redecker A G, Reynolds T B, Waxmann A D. Differences in intrahepatic portal-systemic shunting inb alcoholic and non alcoholic liver disease as assessed by liver scan, portal pressure, and E.coli antibodies. Digestive Disease and Sciences 1980; 24: 509–513
   Google Scholar
• Stemerowicz R, Hpf U, Müller C, Wittenbrink C, Rodloff A, Reinhardt R, Freudenberg M, Galanos C. Are mitochondrial antibodies in primary biliary cirrhosis induced by R(rough)-mutants of enterobacteriacae?. Lancet 1988; 11: 1166–1170
   Google Scholar
• Hopf U, Möller C, Stemerowicz R, Rodloff A, Lobeck H, Freudenberg M, Galanos C, Huhn D. Escherichia coli rough (R) mutants in the gut and lipid A in the liver from patients with primary biliary cirrhosis (PBC). Lancet 1989; 11: 1419–1422
   Google Scholar
• Wenzel B, Heesemann J, Wenzel K W, Scriba P C. Antibodies to plasmid-encoded proteins ofentero-pathogenic Yersinia in patients with autoimmune thyroid disease. Lancet 1988; 1: 56
   PubMedGoogle Scholar
• Hopf U, Meyer zum Büschenfelde K H, Arnold W. Detection of a liver membrane autoantibody in HB, Ag-negative chronic active hepatitis. New Engl J Med 1976; 294: 578–582
   PubMed Web of Science ®Google Scholar
• Hopf U, Jahn H-U, Möller B, Stemerowicz R, Wittenbrink C, Klein R, Berg P A. Liver membrane antibodies (LMA) recognize a 26,000 molecular wight protein on the hepatocellular surface. Clin exp Immunol 1990; 79: 54–61
   PubMedGoogle Scholar
• Westphal O, Lüderitz O, Bister F. Über die Extraktion von Bakterien mit Phenol/Wasser. Zeitsch Narurforsch 1953; 76: 148
   Google Scholar
• Galanos C, Lüderitz O, Rietschel E T, Westphal O. Newer aspects of the biochemistry and biology of bacterial lipopolysaccharides with special reference to their lipid A component. International review of biochemistry. Biochemistry of lipids 11. Vol. 14, T. W. Godwin. University Park Press, Baltimore 1977; 239
   Google Scholar
• Galanos C, Freu enberg M, Hase S, Jay F, Ruschmann E. Biological activities and immunological properties of lipid A. Microbiology Am Soc Microbiol., D. Schlesinger, 1977; 269–276
   Google Scholar
• Heesemann J, Gross U, Schmidt N, Laufs R. Immunochemcial analysis of plasmid-encoded proteins by enteropathogenic Yersinia sp. grown in calcium deficient media. Infet Immun 1986; 54: 561–567
   PubMed Web of Science ®Google Scholar
• Mancini G, Carbonara A O, Hereman I F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 1965; 2: 235–254
   PubMedGoogle Scholar
• Nonomura A, Tanino M, Kurmaya H, Ohta G, Kato Y, Kobayashi K. Disordered immunoregulat-ory functions in patients with chronic active hepatitis. Clin exp Immunol 1982; 47: 595–605
   PubMedGoogle Scholar
• Nuori-Aria K T, Hegarta J E, Alexander G JM, Eddleston AL WF, Williams R. Effect of corticos-teroids on suDressocell activity in “autoimmune” and viral chronic active hepatitis. New Engl J Med 1982; 307: 13101–1382
   Google Scholar
• Alexander G JM, Nouri K, Hegarty J E, Eddleston AL WF, Williams R. Relationship of T-cell subsets to smressor cell function in chronic liver disease. Gut 1982; 23: A 461
   Google Scholar
• Thomas H C, Brown D, Routhier G, Janossy G, Kung P C, Goldstein G, Sherlock S. Inducer and suppressor T-cells in hepatitis B virus induced liver disease. Hepatology 1982; 2: 202–206
   PubMed Web of Science ®Google Scholar
• Alexander G JM, Nouri-Aria K T, Eddleston AL WF, Williams R. Contrasting relations between suppressor-cell function and suppressor-cell number in chronic liver disease. Lancet 1983; 1: 1291–1293
   PubMedGoogle Scholar
• Moller B, Hopf U, Martin P, Galanos C. Detection and characterization of antibodies against Lipopolysaccharides (LPS) from E.ro/i and frcc lipid A in healthy subjects and patients with chronic liver diseases. Immunobiology Suppl 1983
   Google Scholar
• Nolan J P, et al. IgA antibody to lipid A in alcoholic liver disease. Lancet 1986; 1: 176–179
   PubMed Web of Science ®Google Scholar
• Ali M V, Nolan J P. Alcohol induced depression of the reticuloendothelial function in the rat. Journal of Lahoratory and Clinical Medicine 1967; 10: 295–301
   Google Scholar
• Martini G A, Phedr E A, Reuner B. The bacterial content of the small intestine in normal and cirrhotic patients, relation to methionine toxicity. Clinical Science 1957; 16: 35–51
   PubMed Web of Science ®Google Scholar
• Staun-Olsen P, Bjoernebore M, Prytz H, Thomsen A C, Orskov F. Escherichia coli antibodies in alcoholic liver disease. Correlation to alcohol consumption, alcoholic hepatitis, and serum IgA. Scand J Gastrornterol 1983; 18: 889–896
   PubMed Web of Science ®Google Scholar
• Lachman E, Pitsoe S B, Gafin S L. Antilipopolysaccharide immunotherapy in management of septic shock of obstetric and gynaecological origin. Lancet 1984; 1: 981–983
   PubMedGoogle Scholar
• Thomas H C, Vaez-Zadeh F. A homeostatic mechanism for the removal of antigen from the portal circulation. Immunology 1974; 26: 375–382
   PubMedGoogle Scholar
• Hopf U, Schaefer H E, Hess G, Meyer zum Büshenfelde K H. In vivo uptake of immune complexes by parenchymal and nonparenchymal liver cells in mice. Gastroenterology 1981; 80: 250–259
   PubMedGoogle Scholar
• Galanos C, Freudenberg M A, Reutter W. Galaktosamine-induced sensitization to the effects of endotoxin. Proc natl Acad Sci USA 1979; 76: 5359–5943
   Google Scholar
• Liehr H, Grün M, Thiel H, Brunswig D, Rasenack U. Endotoxin-induced liver necrosis and intravascular coagulation in rats enhanced by portocaval collateral circulation. Gut 1975; 16: 429–436
   PubMed Web of Science ®Google Scholar
• Ferluga J, Allison A C. Hypothesis. Role of mononuclear infiltrating cells in pathogenics of hepatitis. Lancet 1978; 2: 610–611
   PubMed Web of Science ®Google Scholar